Abstract
Background: Multisystem inflammatory syndrome in children (MIS-C) is a novel severe postinfectious condition associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The purpose of this report is to describe nationwide trends in the evolving clinical management of MIS-C.
Methods: Patients with MIS-C were reported from state and local jurisdictions to the Centers for Disease Control and Prevention’s (CDC’s) MIS-C national surveillance system. Patients’ case reports were reviewed to ensure that they met the CDC MIS-C case definition and had sufficient data for analysis. The prevalence of use of treatments for MIS-C, temporal trends in use of these treatments, and frequency of administration of different treatment combinations were analyzed.
Results: There were 4470 patients meeting the MIS-C case definition with onset dates from 19 February 2020 to 31 July 2021. The proportion of patients admitted to an intensive care unit (ICU) has declined over time, from 78.7% in April 2020 to 57.5% in June 2021 (P = .001). The most common treatments were intravenous immunoglobulin (IVIG), given to 85.6% of patients; steroids (77.7%), and antiplatelet medications (73.7%); use of each of these treatments has increased over time, particularly in patients not requiring admission to an ICU (all P < .001). Older patients and non-Hispanic Black patients were more likely to receive additional modes of therapy including vasoactive medication, noninvasive respiratory support, anticoagulation medication, and intubation/mechanical ventilation.
Conclusions: IVIG, steroids, and antiplatelet medication have become increasingly utilized as standard treatment for MIS-C patients, while the use of other treatments may be contingent on the type and severity of clinical findings.
Keywords: MIS-C; SARS-CoV-2; multisystem inflammatory syndrome in children; surveillance; treatment.
【저자키워드】 SARS-CoV-2, multisystem inflammatory syndrome in children, MIS-C, Treatment., Surveillance, 【초록키워드】 Treatment, Intravenous immunoglobulin, coronavirus, therapy, anticoagulation, intensive care, children, severity, Ventilation, Local, prevention, Steroids, Case report, ICU, Prevalence, Clinical findings, CDC, Patient, Control, Clinical management, medication, Admission, patients, Combination, administration, Frequency, Analysis, antiplatelet, Inflammatory, Postinfectious, steroid, Support, acute respiratory syndrome, standard treatment, syndrome, center, National, Vasoactive, analyzed, proportion, reported, increasingly, declined, receive, Black patient, noninvasive respiratory, other treatment, 【제목키워드】 United States, trend,